[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 6, Issue 1 (6-2022) ::
CRMS 2022, 6(1): 48-57 Back to browse issues page
The effect of hydroxychloroquine in COVID-19 patients who did not receive corticosteroids
P Ebrahimi , A Zabihzade , N Khodadad , H Shirafkan , M Sadeghi , S H Abedi *
Department of Internal Medicine, School of Medicine, Babol University of Medical Sciences, Babol, I.R Iran , h.abedi@doctor.com
Abstract:   (1297 Views)
Background and Objective: At the beginning of the pandemic, Hydroxychloroquine (HCQ) was one of the most widely used drugs prescribed to patients admitted to hospitals with coronavirus disease 2019 (COVID-19). We try to find the effect of HCQ on the severity and mortality of patients who did not receive corticosteroids.
Methods: In this retrospective study, patients with COVID-19 disease were collected from February 20, 2020, to July 21, 2020, at Rouhani Hospital in Babol. Patients were followed up until December 6, 2021. In this study, 170 patients in case and control groups were studied. We used logistic and COX regression models to explore the effects of drugs. Data were analyzed by SPSS version 22.
Findings: The use of HCQ did not affect mortality (p=0. 46, 95%CI= 0.63 to 2.71, OR= 1.31) and final severity (p= 0.75, 95%CI= 0.59 to 2.06, OR= 1.10) at admission time. However, azithromycin remained in the final model but did not have a significant effect (P= 0.08, HR= 0.28, 95%CI= 0.06 to 0.18). Heparin use was not associated with severity improvement (p= 0.06, 95%CI= 0.97 to 2.81, HR= 1.65), while ceftriaxone remained a factor affecting severity in the model (p = 0.03, 95% CI= 0.29 to 0.95, HR = 0.52).
Conclusion: In this study, HCQ harmed mortality admission time and was ineffective in the long term. The use of ceftriaxone compared to other drugs showed protective effects against the mortality hospitalization time. Heparin is not recommended without considering the risk of bleeding in COVID-19 patients.
 
Article number: 7
Keywords: COVID-19, HCQ, Hydroxychloroquine, Mortality, Coronavirus
Full-Text [PDF 749 kb]   (904 Downloads)    
Type of Study: Original Article | Subject: عفونی ، اطفال
Received: 2022/12/27 | Accepted: 2022/12/28 | Published: 2023/01/29
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ebrahimi P, Zabihzade A, Khodadad N, Shirafkan H, Sadeghi M, Abedi S H. The effect of hydroxychloroquine in COVID-19 patients who did not receive corticosteroids. CRMS 2022; 6 (1) : 7
URL: http://crms.mubabol.ac.ir/article-1-135-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6, Issue 1 (6-2022) Back to browse issues page
Current Research in Medical Sciences
Persian site map - English site map - Created in 0.09 seconds with 37 queries by YEKTAWEB 4710